Stefan Agewall
Stefan Agewall
Association of Glucagon-like Peptide-1 Receptor Agonists with Risk of Gastrointestinal Adverse Events: Evidence from A Drug Target Mendelian Randomization [0.03%]
基于药物靶点的孟德尔随机化研究胰高血糖素样肽-1受体激动剂与消化系统不良事件风险的关系
Hao-Zhang Huang,Jin Liu,Xiaozhao Lu et al.
Hao-Zhang Huang et al.
Sacubitril/valsartan and Quality of Life Assessed Using the EuroQol 5-Dimension 3-Level Questionnaire Level Sum Score (EQ-5D-3L-LSS) in Patients with HFrEF and HFmrEF/HFpEF [0.03%]
在HFrEF和HFmrEF/HFpEF患者中使用EuroQol五维三水平量表总分评价沙库巴曲缬沙坦对生活质量的影响
Mingming Yang,Alasdair D Henderson,Inder S Anand et al.
Mingming Yang et al.
Objectives: To investigate the EQ-5D-3L Level Sum Score (LSS) in patients with heart failure (HF) and reduced (HFrEF) and mildly reduced or preserved ejection fraction (HFmrEF/HFpEF) and the effect of sacubitril/valsartan...
Simone Finocchiaro,Placido Maria Mazzone,Nicola Ammirabile et al.
Simone Finocchiaro et al.
Cardiovascular disease (CVD) remains the leading global cause of morbidity and mortality. In addition to traditional risk factors, inflammation is established as a key mechanism in the initiation, progression, and complications of CVD. Elev...
Impact of left ventricular ejection fraction on the effect of beta-blocker therapy on one-year mortality in acute coronary syndrome patients [0.03%]
左室射血分数对急性冠脉综合征患者一年内死亡率的影响及β受体阻滞剂的治疗效果
Micha T Maeder,Fabienne Foster-Witassek,Dragana Radovanovic et al.
Micha T Maeder et al.
Aim: While the beneficial effect of beta-blocker (BB) therapy for acute coronary syndrome (ACS) patients with left ventricular ejection fraction (LVEF) 40% is controversial. We assessed the relationship between BB therapy...
Stefan Agewall
Stefan Agewall
Marco Cattaneo
Marco Cattaneo
Sex-related differences in cardiovascular pharmacotherapy: fiction or fact? . Why can't we see the evidence? [0.03%]
心血管药理治疗的性别差异：是真是假？为什么我们没有看到证据？
Juan Tamargo,Eva Delpón
Juan Tamargo
There are sex-related differences (SRD) in body composition and physiology, and in the pharmacokinetics, efficacy, safety and dosing of some cardiovascular drugs. Thus, men and women may respond differently to certain drugs. However, inform...
Interdisciplinary recommendations for recurrent hyperkalaemia: Insights from the GUARDIAN-HK European Steering Committee [0.03%]
GUARDIAN-HK欧洲 steering委员会关于难治性高钾血症的学科交叉推荐意见
Gianluigi Savarese,María Jesús Izquierdo,Clara Bonanad et al.
Gianluigi Savarese et al.
Aims: Recurrent hyperkalaemia (HK) is associated with increased morbidity and mortality, and is common among patients with cardiorenal disease. Many of these patients require renin-angiotensin-aldosterone system inhibitor...
Mattia Galli,Dominick J Angiolillo,Fabio M Pulcinelli
Mattia Galli